Multiple Sclerosis Clinical Trial
Biobank For MS And Other Demyelinating Diseases
Summary
To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls. Samples and data will be available as a shared resource to scientists researching the causes, sub-types, and biomarkers of MS and related demyelinating diseases.
Eligibility Criteria
Inclusion Criteria:
age 18+ able to give informed consent or individuals younger than 18 with parental permission and able to give assent
willing to provide up to 110 ml (50 ml for < 18 years old) of blood via venipuncture
experienced at least one CNS demyelinating event characteristic of MS, TM, NMO, ADEM, or ON
Exclusion Criteria:
history of blood borne pathogens
allogeneic bone marrow transplant
clinical or radiological evidence of stroke, meningitis, or other well characterized diseases of the nervous system (with the exception of MS, TM, NMO, ADEM, or ON).
weight less than 37 pounds
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 10 Locations for this study
Phoenix Arizona, 85013, United States
Stanford California, 94305, United States
Aurora Colorado, 80045, United States
Atlanta Georgia, 30309, United States
Baltimore Maryland, 21287, United States
Boston Massachusetts, 02215, United States
Worcester Massachusetts, 01605, United States
New York New York, 10019, United States
Columbus Ohio, 43210, United States
Dallas Texas, 76051, United States
How clear is this clinincal trial information?